Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

171.82
BATS BZX Real-Time Price
As of 2:53pm ET
 -0.15 / -0.09%
Today’s Change
130.09
Today|||52-Week Range
176.64
+5.85%
Year-to-Date
Regeneron/Sanofi Present Positive Phase III Praluent Data
10:05am / Zacks.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Bil...
Aug 27 / MotleyFool.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Amgen's Shameful Silence Covers Up Reasons for FDA Drug Rejection
Aug 25 / TheStreet.com - Paid Partner Content
3 Cheap Dividend Stocks You Can Buy Right Now
Aug 19 / MotleyFool.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
Aug 25 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
Aug 24 / Zacks.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close171.97
Today’s open172.35
Day’s range171.21 - 172.45
Volume84,293
Average volume (3 months)2,861,785
Market cap$128.7B
Dividend yield2.33%
Data as of 2:53pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+9.46%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio17.6
Price/Sales5.83
Price/Book4.62

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-1.66-2.08%
BIIBBiogen-0.57-0.18%
ILMNIllumina Inc-1.82-1.06%
NBIXNeurocrine Bioscienc...-0.15-0.30%
Data as of 2:53pm ET, 08/29/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers

Search for Jobs